SVA Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
SVA Wealth Management's AGN Position: Q2 2018 in Review
SVA Wealth Management sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 10,266 shares — an estimated $2.1M sold.
SVA Wealth Management first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $6.92M in Q4 2015. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.
- SVA Wealth Management reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
- SVA Wealth Management sold 10,266 Allergan plc shares in Q2 2018, an estimated $2.1M.
- SVA Wealth Management first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
- SVA Wealth Management's Allergan plc position peaked at $6.92M in Q4 2015.
- 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.
Based on SVA Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.